The Max Foundation shared a post on LinkedIn:
“Today we celebrate the resilience of people living with chronic myeloid leukemia (CML), and the progress that’s changing lives around the world.
Did you know?
Patients who’ve been on treatment for many years and whose regular molecular diagnostic tests show they are responding well now have the option to try Treatment Free Remission (TFR) – living without daily medication while still keeping their disease under control.
But here’s what’s truly remarkable:
Through partnerships and innovation, people in low- and middle-income countries are receiving molecular diagnostic tests to monitor their response, providing the opportunity for TFR.
Because everyone deserves the chance to live beyond cancer. Love what you see? Comment “infographic” and we’ll send you the content of this carousel as a downloadable PDF.”
More Posts Featuring The Max Foundation.
